Pan-Cancer Markers for Proteomic Phenotyping
This e-book offers a clear, structured framework for understanding the role of pan-cancer markers in cancer research. Each chapter builds progressively, guiding readers from core biomarker concepts to their potential clinical and translational applications in human cancer.
What you’ll learn:
Chapter 1: An introduction to cancer biomarkers and their critical role in deciphering tumor complexity.
Chapter 2: A deep dive into the genomic landscape of cancer, from The Cancer Genome Atlas (TCGA) to the Pan-Cancer Atlas, highlighting shared molecular pathways across tumor types.
Chapter 3: An exploration of proteomic alterations during tumorigenesis and how proteomic approaches are shaping the future of cancer therapy.
👇 Download your free copy to explore how pan-cancer markers enable deeper proteomic phenotyping across cancers.
Please submit the form
Learn More About Pan-Cancer Markers
The Atlas Antibodies Pan-Cancer Marker Panel includes more than 300 antibodies for tissue and cell analysis. Each antibody is extensively validated across 20 human cancer types, ensuring robust performance and reliable results for comprehensive pan-cancer research.